β-Cell Dysfunction, Insulin Sensitivity, and Glycosuria Precede Diabetes in Hepatocyte Nuclear Factor-1α Mutation Carriers
Open Access
- 1 July 2005
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (7), 1751-1756
- https://doi.org/10.2337/diacare.28.7.1751
Abstract
OBJECTIVE—Patients with diabetes due to hepatocyte nuclear factor (HNF)-1α mutations have β-cell deficiency, insulin sensitivity, altered proinsulin levels, and a low renal threshold for glucose. It is uncertain how many of these features precede the development of diabetes. The aim of our study was to test for these characteristics in young nondiabetic HNF-1α mutation carriers. RESEARCH DESIGN AND METHODS—A total of 47 offspring from 19 extended families underwent genetic testing, a standard oral glucose tolerance test, and urine testing. RESULTS—HNF-1α mutations were found in 20 offspring, 7 with diabetes and 13 without diabetes. The 13 nondiabetic mutation carriers were compared with 27 family control subjects, who were matched for age, sex, and BMI. There was marked β-cell deficiency with reduced insulinogenic index (53.5 [31.5–90.9] vs. 226.0 [126.0–407.1], SD [range], P < 0.001) and area under the curve for insulin (P < 0.001). Insulin sensitivity was increased in mutation carriers (homeostatic model assessment of insulin sensitivity 144.6 [82.7–252.7] vs. 100 [66.9–149.4], P = 0.025). A total of 38% of mutation carriers had glycosuria at 2 h compared with 0% of control subjects (P = 0.0034). Those with glycosuria had peak glucose values that were higher than the mutations carriers without glycosuria (range 8.1–11.8 vs. 6.2–8.4 mmol/l, P = 0.002). The seven subjects with diabetes all showed glycosuria. CONCLUSIONS—We conclude that marked β-cell deficiency, increased insulin sensitivity, and a low renal threshold are present in young nondiabetic HNF-1α mutation carriers. The presence of glycosuria post–glucose load could be used to screen children of mutation carriers as it occurs in all mutation carriers with a peak glucose in the oral glucose tolerance test >8.4 mmol/l.This publication has 29 references indexed in Scilit:
- Different genes, different diabetes: lessons from maturity-onset diabetes of the youngAnnals of Medicine, 2002
- The genetic abnormality in the beta cell determines the response to an oral glucose loadDiabetologia, 2002
- Different genes, different diabetes: lessons from maturity-onset diabetes of the youngAnnals of Medicine, 2002
- Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the YoungThe New England Journal of Medicine, 2001
- Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic stateDiabetologia, 2000
- Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetesDiabetologia, 1999
- Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.JCI Insight, 1997
- Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)Nature, 1996
- Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12Diabetes, 1996
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985